GobyMeds
Compounded and branded pathwaysPublished program descriptions include compounded and brand-name pathways. Confirm availability, prescription requirements and full cost directly.
A clear-eyed guide to pharmacy types, compounded GLP-1 rules, safety checks and treatment options. Understand the medication before comparing offers.
Information only, not medical advice. We may earn commissions when you use some links. Treatment and cost depend on individual circumstances.
Three details worth checking on every provider's own site.
These are paid links to available affiliate programs, not personalized treatment recommendations or a verified ranking. Provider eligibility, formulations and charges may change.
Published program descriptions include compounded and brand-name pathways. Confirm availability, prescription requirements and full cost directly.
HealthRX advertises compounded semaglutide. Compounded products are not FDA-approved; confirm legality, dose, pharmacy and current pricing.
HealthRX advertises compounded tirzepatide. Compounded products are not FDA-approved; confirm legality, dose, pharmacy and current pricing.
Review its advertised GLP-1 care options and confirm which formulations, clinician services and costs are offered in your state.
Ask whether a specific advertised option involves an FDA-approved or compounded medication and confirm your total cost.
Compare telehealth appointment and weight-management options. Medication coverage and prescribing depend on clinical evaluation.
Not sure where to begin? See the expanded comparison and full disclosure →
FDA-approved products undergo agency review for safety and effectiveness. Compounded versions do not. Ask what pharmacy dispenses your prescription, why compounding is clinically necessary, and which regulations apply.
Read FDA guidance ↗Identify the exact medication and whether it is FDA-approved or compounded.
Verify state licensure and who will actually dispense the product.
Confirm consultation, shipping, refill, and dosage-related fees.
Start with independent context and the provider's own published terms.
The FDA clarified restrictions on routine copying of commercially available GLP-1 medicines on April 1, 2026. A compounded medicine is not an FDA-approved substitute merely because it contains a similar ingredient.
Read the FDA clarification →No guaranteed prescriptions or weight loss. No fabricated ratings, fabricated firsthand treatment experiences, or unsupported pharmacy certifications. These listings are commercial links, not proof of provider verification.
How offers are selected and disclosed →